Sunscreen Heresy & Other Hot Takes

Dermatology clinical practice and recent literature updates center on innovative treatment paradigms and safety reassurances for common conditions. A retrospective study on cutaneous T-cell lymphoma demonstrates that combining Brentuximab Vedotin with ultra-low-dose total skin electron beam therapy yields rapid, complete remission in advanced-stage patients. Regarding systemic therapies, large-scale data confirms that interleukin inhibitors for psoriasis do not elevate malignancy risk, providing clinicians with robust safety evidence for shared decision-making. Environmental factors significantly influence hidradenitis suppurativa, with geographic hotspots correlating to heat, pollution, and socioeconomic variables. Furthermore, oral photoprotection strategies using antioxidants like polypodium leucotomus and carotenoids offer potential benefits against sunburn, while topical dihydromyricetin shows promise in reversing epigenetic skin aging. Finally, azithromycin emerges as a well-tolerated alternative for acne, and inhaled corticosteroids are identified as a notable environmental trigger for perioral dermatitis in pediatric populations.